Correlation of CEA levels with metabolic tumor volume, assessed by FDG PET and RECIST complient size measurement in patients with recurrent and/or metastatic colorectal cancer

被引:0
|
作者
Bochev, P. [1 ]
Bocheva, Y. [2 ]
Mateva, G. [1 ]
机构
[1] Acibadem Cityclin UMBAL Mladost Oncol Hosp, Sofia, Bulgaria
[2] Med Univ Prof Dr Paraskev Stoyanov, Varna, Bulgaria
关键词
D O I
暂无
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
EPS-031
引用
收藏
页码:S70 / S70
页数:1
相关论文
共 50 条
  • [11] The utility of FDG-PET/CT as an effective tool for detecting recurrent colorectal cancer regardless of serum CEA levels
    Yasemin Sanli
    Serkan Kuyumcu
    Zeynep Gozde Ozkan
    Leyla Kilic
    Emre Balik
    Cuneyt Turkmen
    Duygu Has
    Goknur Isik
    Oktar Asoglu
    Yersu Kapran
    Isik Adalet
    Annals of Nuclear Medicine, 2012, 26 : 551 - 558
  • [12] The utility of FDG-PET/CT as an effective tool for detecting recurrent colorectal cancer regardless of serum CEA levels
    Sanli, Yasemin
    Kuyumcu, Serkan
    Ozkan, Zeynep Gozde
    Kilic, Leyla
    Balik, Emre
    Turkmen, Cuneyt
    Has, Duygu
    Isik, Goknur
    Asoglu, Oktar
    Kapran, Yersu
    Adalet, Isik
    ANNALS OF NUCLEAR MEDICINE, 2012, 26 (07) : 551 - 558
  • [13] Is positron emission tomography (PET) with FDG an early predictor of the RECIST morphological response to chemotherapy in metastatic colorectal cancer patients (mCRC)?
    Hendlisz, A.
    Emonts, P.
    Covas, A.
    Ameye, L.
    Paesmans, M.
    del Rosario, R. Castany Prado Maria
    Machiels, G.
    Van den Eynde, M.
    Vanderlinden, B.
    Flamen, P.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [14] Correlation between FDG PET imaging results and plasma CEA levels in patients with suspected recurrent colon carcinoma.
    Fournier, RS
    Kilroy, K
    Alavi, A
    JOURNAL OF NUCLEAR MEDICINE, 1999, 40 (05) : 241P - 241P
  • [15] The Prognostic Value Of 18 FDG PET /CT Metabolic Tumor Volume (MTV) In Distant Metastatic Breast Cancer
    Arslan, Esra
    Aksoy, Tamer
    Cermik, Tevfik
    JOURNAL OF NUCLEAR MEDICINE, 2019, 60
  • [16] An evaluation of FDG-PET as a predictor of metabolic response to chemotherapy in metastatic colorectal cancer patients (mCRC).
    Van Damme, N.
    De Bruyne, S.
    Mertens, J.
    Van de Wiele, C.
    Ceelen, W. P.
    Smeets, P.
    Ferdinande, L.
    Laurent, S.
    Geboes, K.
    Peeters, M.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [17] Ability of 18F-FDG PET/CT to diagnose recurrent colorectal cancer in patients with elevated CEA concentrations
    Yukishige Kyoto
    Mitsuru Momose
    Chisato Kondo
    Michio Itabashi
    Shingo Kameoka
    Kiyoko Kusakabe
    Annals of Nuclear Medicine, 2010, 24 : 395 - 401
  • [18] Ability of 18F-FDG PET/CT to diagnose recurrent colorectal cancer in patients with elevated CEA concentrations
    Kyoto, Yukishige
    Momose, Mitsuru
    Kondo, Chisato
    Itabashi, Michio
    Kameoka, Shingo
    Kusakabe, Kiyoko
    ANNALS OF NUCLEAR MEDICINE, 2010, 24 (05) : 395 - 401
  • [19] Performance of FDG-PET/CT in postoperative colorectal cancer patients with a suspected recurrent finding and a normal CEA level
    Lee, Jai Hyuen
    JOURNAL OF NUCLEAR MEDICINE, 2010, 51
  • [20] Correlation between metabolic tumor volume and prognostic hematological parameters in patients with colorectal cancer
    Cengiz, A.
    Yurekli, Y.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2017, 44 : S695 - S696